Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Overdose deaths rose by nearly 5% in 2019, and the pandemic could make matters worse.
This is one of many ways that people who use drugs can engage in harm reduction during the coronavirus pandemic.
A national survey found that primary care physicians had little interest in prescribing buprenorphine or naltrexone.
Experts are calling for greater flexibility in clinicians’ ability to deliver treatments for opioid use disorder.
One bill would create 1,000 new residency positions for physicians going into addiction treatment medicine.
A systematic review of hep C treatment outcomes in this population shows they have high cure rates and relatively low reinfection rates.
Researchers found critical gaps in the scientific knowledge about the opioid epidemic.
Researchers analyzed rates of use of buprenorphine, which is used to treat opioid use disorder, between 2009 and 2018.
A literature review shows promising signs that teenagers, like adults, can benefit from methadone, buprenorphine and naltrexone.
Researchers followed people with a drug-injection history who had been cured of hepatitis C and were receiving addiction treatment.
The drug can quickly reverse an opioid overdose and prevent death.
Researchers used mathematical modeling to analyze the benefits of treating with buprenorphine/naloxone on-site.
Plans have increasingly instituted preauthorization requirements for the opioid medication-assisted treatment buprenorphine.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.